Competitive Intelligence

R1 RCM: Services Capabilities for HCP, 2026

The R1 RCM: Services Capabilities for HCP, 2026 profile is for health system CFOs, revenue cycle leaders, and patient financial services executives evaluating end-to-end RCM operating partners.

HFS Horizons placement grid plotting service providers across three horizons against two axes. The left vertical axis, innovation scope, runs from Functional at the bottom, through Enterprise in the middle, to Network at the top. The right vertical axis, value aspiration, runs from Cost plus Experience at the bottom, through Experience plus Health in the middle, to Health plus Equity at the top. The three horizon bands are stacked top to bottom. Horizon 3 Market Leaders sits at the top and represents providers delivering on the full quadruple aim of cost, experience, health outcomes, and equity. Horizon 2 Enterprise Innovators sits in the middle and represents enterprise transformation that delivers cost, experience, and health outcomes. Horizon 1 Disruptors sits at the bottom and represents providers addressing cost and experience. All providers within a horizon are listed alphabetically. Horizon 3 Market Leaders includes Accenture, Cognizant, Deloitte, Epic, Evernorth Health Services, EY, HCLTech, Hitachi Digital Services, KPMG, Kyndryl, Optum, Sagility, and Tata Consultancy Services. Horizon 2 Enterprise Innovators includes Atos, Capgemini, Carelon, CitiusTech, Ensemble Health Partners, EXL, Firstsource, Genpact, Guidehouse, IBM, Innova Solutions, Inovalon, MEDITECH, NTT DATA, Omega Healthcare, Oracle Cerner, Publicis Sapient, PwC, R1, SoftServe, Sutherland, UST, Virtusa, and Wipro. Horizon 1 Disruptors includes AKKODiS, Coforge, DXC Technology, Emids, EPAM, Hexaware, HTC Global Services, LTM, Persistent, Smarter Technologies, Sonata, and Tech Mahindra. R1 RCM, shown as R1, is placed in Horizon 2 Enterprise Innovator. The accompanying callout summarizes R1 RCM as a pure-play RCM operator scaling agentic AI via the Phare operating system. The study assessed and rated the service capabilities of 50 healthcare providers at the intersection of the why, what, how, and so what, and the quadruple aim of care. Source: HFS Research, 2026.

Note: All service providers within a Horizon are listed alphabetically
Source: HFS Research, 2026

Key facts about R1 RCM’s HCP services capabilities

Information panel divided into five blocks summarizing R1 RCM's HCP services profile. The first block, relevant M&A and partnerships, lists recent M&A from 2022 to 2025: Phare Health in 2025, an AI platform for automating inpatient coding and pre-bill clinical documentation improvement; Acclara in 2024, revenue cycle management services; and Cloudmed in 2022, Revenue Intelligence solutions for healthcare providers. Its partnerships are Palantir, Automation Anywhere, Iodine Software, Microsoft Azure, and Epic. The second block, key clients, states a client count of 3,700 or more, with key clients Ascension, Intermountain Health, LifePoint Health, Providence, and Sutter Health. The third block, global operations and resources, states a headcount of 25,000 or more, with delivery centers across the US and India. The fourth block, flagship internal IP, lists three entries: Phare OS, an end-to-end RCM workflow orchestration platform spanning access, claim, and flow; R37 AI Lab, a system-level AI and analytics framework enabling predictive denials management, real-time adjudication, and agentic automation; and Insurance Discovery, a proprietary capability improving coverage detection and patient financial clearance upstream. The fifth block, sustainability meter, is a gauge dial reading from Low through Medium to High, with the needle pointing to Medium. Source: HFS Research, 2026.

Source: HFS Research, 2026

R1 RCM’s performance in the study and HFS’ views of its strengths and development opportunities for HCP services capabilities

Two-part assessment slide accompanied by a horizon ribbon on the left that marks R1 RCM's placement in Horizon 2 Enterprise Innovator, between Horizon 3 Market Leader above and Horizon 1 Disruptor below. The first part lists strengths across six dimensions. Value proposition: an end-to-end RCM operating partner anchored in financial performance, cash acceleration, and administrative efficiency. Capabilities: addresses the entire RCM stretch of the provider value chain, including patient access, eligibility, mid-cycle coding and CDI, claims, denials, and AR follow-up, with end-to-end, modular, and software-only delivery models. Go-to-market: targets large US health systems with enterprise-led selling, supported by exclusive long-term operating partnerships. Outcomes: quantifiable financial outcomes at scale, including multi-million-dollar denials recovery and automation-led cost reduction. Innovation: operational innovation anchored in the R37 AI Lab and agentic use cases across adjudication and coding. Partner: anchored on exclusive AI partnerships, deep EHR interoperability, hyperscaler depth, and broad payer connectivity that collectively differentiate R1's operating posture. The second part lists development opportunities across six dimensions. Value proposition: articulating impact on the quadruple aim beyond financial outcomes will be increasingly critical as buyers seek RCM partners who also support patient experience and access. Capabilities: expanding beyond RCM into adjacent value chain areas such as clinical workflow, virtual care, and population health must be considered to hedge pure-play concentration risk. Go-to-market: a deliberate focus on international markets and the mid-market care segment must be developed to hedge enterprise-deal concentration and tightening US health system economics. Outcomes: quantified value across the quadruple aim will be increasingly critical to enhance buyer resonance. Innovation: an enterprise innovation framework with structured client co-development is key to optimizing investments and delivering predictable, durable value. Partner: a more diversified partner ecosystem will accelerate value creation and reduce platform dependency that limits buyer flexibility. Source: HFS Research, 2026.

Source: HFS Research, 2026

To read the complete report, click the download button below.

Sign in to view or download this research.

Login

Register

Insight. Inspiration. Impact.

Register now for immediate access of HFS' research, data and forward looking trends.

Get Started

Authors

Related

Download Research

    Sign In

    Sign up for a free
    research account

    With the exception of our Horizons reports, most of our research is available for free on our website. Sign up for a free account and start realizing the power of insights now.

    Digests/Newsletters: Overviews of the latest news, insight, and research by HFS.

    HFS Events: Exclusive invitations to HFS webinars, roundtables, and summits, bringing together key industry stakeholders focused on major innovations impacting business operations.

    By registering you agree to our privacy policy.

    I hereby consent that HFS Research can process my personal data.

    Premium Access

    Our premium subscription gives enterprise clients access to our complete library of proprietary research, direct access to our industry analysts, and other benefits.

    Contact us at [email protected] for more information on premium access.

    Help

    If you are looking for help getting in touch with someone from HFS, please click the chat button to the bottom right of your screen to start a conversation with a member of our team.

    [email protected]

      Contact Ask HFS AI Support